ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Aside from its role in preventing insulin resistance, FA also has a relationship with metabolic syndrome, atherogenic dyslipidemia and reduced adiponectin levels, and risk factors for nonalcoholic fatty liver disease and might also be involved in fibrosis of liver [21].